Allan Prochazka
Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking Cessation | 11 | 2023 | 407 | 1.950 |
Why?
| Informed Consent | 6 | 2022 | 168 | 1.000 |
Why?
| Internal Medicine | 7 | 2016 | 246 | 0.990 |
Why?
| Preventive Health Services | 5 | 2020 | 145 | 0.970 |
Why?
| Diagnostic Tests, Routine | 3 | 2014 | 101 | 0.850 |
Why?
| Disease | 2 | 2013 | 94 | 0.790 |
Why?
| Health Status Indicators | 2 | 2013 | 166 | 0.790 |
Why?
| Early Diagnosis | 2 | 2013 | 234 | 0.770 |
Why?
| Hospitalists | 3 | 2013 | 231 | 0.750 |
Why?
| Cancer Survivors | 5 | 2025 | 263 | 0.740 |
Why?
| Physical Examination | 3 | 2015 | 230 | 0.710 |
Why?
| Down Syndrome | 3 | 2021 | 469 | 0.680 |
Why?
| Stress Disorders, Post-Traumatic | 3 | 2016 | 821 | 0.580 |
Why?
| Motivational Interviewing | 3 | 2016 | 100 | 0.570 |
Why?
| Weight Reduction Programs | 2 | 2016 | 111 | 0.550 |
Why?
| Anticoagulants | 3 | 2007 | 615 | 0.540 |
Why?
| Internship and Residency | 5 | 2016 | 1043 | 0.520 |
Why?
| Varenicline | 1 | 2016 | 26 | 0.510 |
Why?
| Comprehension | 3 | 2014 | 165 | 0.500 |
Why?
| Quality of Health Care | 4 | 2018 | 605 | 0.500 |
Why?
| Veterans | 8 | 2023 | 1397 | 0.490 |
Why?
| Patient Readmission | 4 | 2015 | 663 | 0.470 |
Why?
| Nicotinic Agonists | 1 | 2016 | 125 | 0.460 |
Why?
| Telemedicine | 3 | 2023 | 781 | 0.450 |
Why?
| Educational Measurement | 1 | 2016 | 257 | 0.440 |
Why?
| Patient Satisfaction | 3 | 2015 | 624 | 0.440 |
Why?
| Warfarin | 2 | 2005 | 142 | 0.430 |
Why?
| Telenursing | 1 | 2013 | 9 | 0.420 |
Why?
| Combat Disorders | 1 | 2013 | 37 | 0.410 |
Why?
| Radiography, Thoracic | 1 | 2014 | 163 | 0.410 |
Why?
| Students, Medical | 2 | 2016 | 315 | 0.410 |
Why?
| Acute Coronary Syndrome | 1 | 2016 | 267 | 0.400 |
Why?
| Iraq War, 2003-2011 | 1 | 2013 | 125 | 0.400 |
Why?
| Hospitalization | 4 | 2016 | 2057 | 0.400 |
Why?
| Afghan Campaign 2001- | 1 | 2013 | 130 | 0.400 |
Why?
| Gastric Bypass | 1 | 2013 | 107 | 0.380 |
Why?
| Ambulatory Care Facilities | 1 | 2013 | 226 | 0.370 |
Why?
| Preoperative Care | 1 | 2014 | 335 | 0.370 |
Why?
| Bibliometrics | 1 | 2012 | 53 | 0.370 |
Why?
| Patient Discharge | 3 | 2015 | 850 | 0.370 |
Why?
| Clinical Trials as Topic | 2 | 2016 | 997 | 0.360 |
Why?
| Humans | 65 | 2025 | 128019 | 0.360 |
Why?
| Overweight | 1 | 2015 | 522 | 0.350 |
Why?
| Depression | 3 | 2016 | 1290 | 0.340 |
Why?
| Adult | 27 | 2021 | 35176 | 0.340 |
Why?
| Publishing | 1 | 2012 | 140 | 0.340 |
Why?
| Weight Loss | 1 | 2015 | 725 | 0.330 |
Why?
| Obesity, Morbid | 1 | 2013 | 239 | 0.330 |
Why?
| Primary Health Care | 3 | 2015 | 1639 | 0.330 |
Why?
| Tobacco Use Disorder | 3 | 2023 | 237 | 0.320 |
Why?
| Lung Neoplasms | 4 | 2023 | 2327 | 0.320 |
Why?
| United States | 18 | 2021 | 13785 | 0.320 |
Why?
| Aged | 20 | 2023 | 21892 | 0.310 |
Why?
| Ethics, Medical | 2 | 2012 | 78 | 0.310 |
Why?
| Smoking | 4 | 2017 | 1459 | 0.300 |
Why?
| Attitude of Health Personnel | 4 | 2016 | 1088 | 0.300 |
Why?
| Publications | 1 | 2008 | 41 | 0.290 |
Why?
| Research Design | 2 | 2020 | 1034 | 0.280 |
Why?
| Ofloxacin | 2 | 2005 | 24 | 0.270 |
Why?
| International Normalized Ratio | 2 | 2005 | 44 | 0.270 |
Why?
| Physicians | 5 | 2016 | 858 | 0.270 |
Why?
| Levofloxacin | 2 | 2005 | 25 | 0.270 |
Why?
| Vena Cava Filters | 1 | 2007 | 59 | 0.270 |
Why?
| Physician-Patient Relations | 5 | 2015 | 529 | 0.270 |
Why?
| Rheumatology | 1 | 2008 | 106 | 0.270 |
Why?
| Middle Aged | 22 | 2021 | 30812 | 0.270 |
Why?
| Personnel Staffing and Scheduling | 2 | 2010 | 87 | 0.260 |
Why?
| Male | 29 | 2021 | 62757 | 0.250 |
Why?
| Pulmonary Embolism | 1 | 2007 | 202 | 0.240 |
Why?
| Obesity | 2 | 2016 | 2859 | 0.240 |
Why?
| Rehabilitation Centers | 2 | 2015 | 37 | 0.240 |
Why?
| Female | 30 | 2021 | 68016 | 0.240 |
Why?
| Nortriptyline | 1 | 2004 | 11 | 0.240 |
Why?
| Physicians, Family | 2 | 2009 | 203 | 0.230 |
Why?
| Communication | 5 | 2014 | 838 | 0.230 |
Why?
| Medical Staff, Hospital | 2 | 2016 | 77 | 0.230 |
Why?
| Teaching Rounds | 2 | 2016 | 68 | 0.220 |
Why?
| Biomarkers | 2 | 2022 | 3874 | 0.220 |
Why?
| Burnout, Professional | 2 | 2010 | 407 | 0.220 |
Why?
| Insurance, Health, Reimbursement | 2 | 2015 | 94 | 0.210 |
Why?
| Telerehabilitation | 1 | 2023 | 36 | 0.200 |
Why?
| Surveys and Questionnaires | 12 | 2021 | 5353 | 0.200 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2025 | 146 | 0.200 |
Why?
| Anti-Infective Agents | 1 | 2005 | 243 | 0.200 |
Why?
| Confidence Intervals | 3 | 2021 | 316 | 0.200 |
Why?
| Substance Withdrawal Syndrome | 1 | 2004 | 171 | 0.200 |
Why?
| Follow-Up Studies | 6 | 2018 | 4853 | 0.190 |
Why?
| Hearing Aids | 1 | 2023 | 74 | 0.190 |
Why?
| Nicotine | 1 | 2004 | 302 | 0.190 |
Why?
| Deafness | 1 | 2023 | 79 | 0.190 |
Why?
| Neoplasms | 3 | 2025 | 2460 | 0.180 |
Why?
| Time Factors | 9 | 2021 | 6479 | 0.180 |
Why?
| Leisure Activities | 1 | 2021 | 29 | 0.180 |
Why?
| Cohort Studies | 5 | 2018 | 5378 | 0.180 |
Why?
| Smoking Prevention | 2 | 2017 | 161 | 0.170 |
Why?
| Health Knowledge, Attitudes, Practice | 3 | 2008 | 1272 | 0.170 |
Why?
| Retrospective Studies | 7 | 2020 | 14404 | 0.170 |
Why?
| Hearing Loss | 1 | 2023 | 210 | 0.170 |
Why?
| Quality of Life | 5 | 2025 | 2672 | 0.160 |
Why?
| Statistics, Nonparametric | 2 | 2012 | 419 | 0.140 |
Why?
| Logistic Models | 4 | 2021 | 1975 | 0.140 |
Why?
| Odds Ratio | 2 | 2012 | 1018 | 0.140 |
Why?
| Cross-Sectional Studies | 7 | 2023 | 5034 | 0.130 |
Why?
| Financing, Organized | 1 | 2016 | 30 | 0.130 |
Why?
| Interdisciplinary Studies | 1 | 2016 | 28 | 0.130 |
Why?
| Clinical Competence | 2 | 2014 | 1007 | 0.130 |
Why?
| Medicaid | 1 | 2020 | 433 | 0.130 |
Why?
| Prenatal Care | 1 | 2018 | 274 | 0.130 |
Why?
| Evidence-Based Medicine | 3 | 2016 | 709 | 0.130 |
Why?
| Surgeons | 1 | 2020 | 259 | 0.130 |
Why?
| Contraindications | 1 | 2015 | 87 | 0.120 |
Why?
| Delivery of Health Care | 2 | 2020 | 888 | 0.120 |
Why?
| Learning | 2 | 2016 | 393 | 0.120 |
Why?
| Pre-Exposure Prophylaxis | 1 | 2018 | 202 | 0.120 |
Why?
| Decision Support Systems, Management | 1 | 2015 | 6 | 0.120 |
Why?
| Preventive Medicine | 1 | 2015 | 41 | 0.120 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2025 | 1356 | 0.120 |
Why?
| Risk Assessment | 4 | 2015 | 3223 | 0.120 |
Why?
| Pilot Projects | 3 | 2023 | 1559 | 0.120 |
Why?
| Patient Care | 1 | 2016 | 108 | 0.120 |
Why?
| Treatment Outcome | 7 | 2025 | 10110 | 0.120 |
Why?
| United States Department of Veterans Affairs | 1 | 2018 | 633 | 0.110 |
Why?
| Teaching | 1 | 2016 | 210 | 0.110 |
Why?
| Disclosure | 2 | 2012 | 110 | 0.110 |
Why?
| Curriculum | 2 | 2013 | 909 | 0.110 |
Why?
| Data Interpretation, Statistical | 2 | 2014 | 335 | 0.110 |
Why?
| Substance Abuse Treatment Centers | 1 | 2014 | 40 | 0.110 |
Why?
| Costs and Cost Analysis | 2 | 2013 | 200 | 0.110 |
Why?
| Faculty, Medical | 1 | 2016 | 263 | 0.110 |
Why?
| Patient Transfer | 1 | 2015 | 161 | 0.110 |
Why?
| Tomography, X-Ray Computed | 2 | 2013 | 2509 | 0.110 |
Why?
| Incidental Findings | 1 | 2014 | 79 | 0.110 |
Why?
| Guidelines as Topic | 2 | 2013 | 260 | 0.100 |
Why?
| Inpatients | 2 | 2017 | 464 | 0.100 |
Why?
| Nursing Homes | 1 | 2015 | 154 | 0.100 |
Why?
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2013 | 34 | 0.100 |
Why?
| Mental Recall | 1 | 2014 | 185 | 0.100 |
Why?
| Medication Adherence | 1 | 2018 | 559 | 0.100 |
Why?
| Drug Interactions | 2 | 2005 | 361 | 0.100 |
Why?
| Research | 1 | 2016 | 408 | 0.100 |
Why?
| Patient Care Management | 1 | 2013 | 56 | 0.100 |
Why?
| Administration, Oral | 2 | 2005 | 766 | 0.100 |
Why?
| Aged, 80 and over | 4 | 2015 | 7029 | 0.100 |
Why?
| Early Medical Intervention | 1 | 2013 | 57 | 0.100 |
Why?
| Health Literacy | 1 | 2014 | 161 | 0.100 |
Why?
| Pharmacists | 1 | 2015 | 246 | 0.100 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 251 | 0.100 |
Why?
| Practice Patterns, Physicians' | 2 | 2015 | 1260 | 0.100 |
Why?
| Morbidity | 1 | 2013 | 301 | 0.100 |
Why?
| Self Care | 1 | 2015 | 368 | 0.100 |
Why?
| Chemoembolization, Therapeutic | 1 | 2012 | 48 | 0.090 |
Why?
| Government Regulation | 1 | 2012 | 49 | 0.090 |
Why?
| Perception | 1 | 2014 | 336 | 0.090 |
Why?
| Methotrexate | 1 | 2013 | 249 | 0.090 |
Why?
| Adolescent | 5 | 2021 | 20158 | 0.090 |
Why?
| Nurse's Role | 1 | 2013 | 139 | 0.090 |
Why?
| Hospitals, University | 1 | 2012 | 176 | 0.090 |
Why?
| Health Services Accessibility | 1 | 2018 | 895 | 0.090 |
Why?
| Risk | 1 | 2014 | 850 | 0.090 |
Why?
| National Institutes of Health (U.S.) | 1 | 2012 | 122 | 0.090 |
Why?
| Anti-HIV Agents | 1 | 2018 | 749 | 0.090 |
Why?
| Primary Prevention | 1 | 2013 | 186 | 0.090 |
Why?
| Radiography, Interventional | 1 | 2012 | 104 | 0.090 |
Why?
| Hospital Costs | 1 | 2012 | 114 | 0.090 |
Why?
| Drug Therapy, Combination | 2 | 2004 | 1012 | 0.090 |
Why?
| United States Food and Drug Administration | 1 | 2012 | 197 | 0.090 |
Why?
| Mortality | 1 | 2013 | 306 | 0.090 |
Why?
| Glucocorticoids | 1 | 2015 | 572 | 0.090 |
Why?
| Antirheumatic Agents | 1 | 2013 | 278 | 0.090 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 1482 | 0.090 |
Why?
| Hospitals | 1 | 2015 | 631 | 0.090 |
Why?
| Decision Making | 2 | 2014 | 846 | 0.090 |
Why?
| Work Schedule Tolerance | 2 | 2010 | 42 | 0.080 |
Why?
| Interviews as Topic | 1 | 2013 | 714 | 0.080 |
Why?
| Colorado | 5 | 2020 | 4369 | 0.080 |
Why?
| Information Dissemination | 1 | 2012 | 203 | 0.080 |
Why?
| Early Detection of Cancer | 1 | 2014 | 369 | 0.080 |
Why?
| Carcinoma, Hepatocellular | 1 | 2012 | 270 | 0.080 |
Why?
| Exercise | 1 | 2021 | 1917 | 0.080 |
Why?
| Reproducibility of Results | 2 | 2014 | 3009 | 0.080 |
Why?
| Adaptation, Psychological | 1 | 2014 | 616 | 0.080 |
Why?
| Feasibility Studies | 1 | 2013 | 860 | 0.080 |
Why?
| Health Care Surveys | 2 | 2015 | 556 | 0.080 |
Why?
| Age Factors | 4 | 2015 | 3100 | 0.080 |
Why?
| Counseling | 3 | 2023 | 382 | 0.080 |
Why?
| Socioeconomic Factors | 3 | 2021 | 1211 | 0.080 |
Why?
| Databases, Bibliographic | 1 | 2008 | 30 | 0.080 |
Why?
| Beneficence | 1 | 2008 | 17 | 0.070 |
Why?
| Catheter Ablation | 1 | 2012 | 333 | 0.070 |
Why?
| Patient Care Team | 1 | 2013 | 597 | 0.070 |
Why?
| Job Satisfaction | 2 | 2010 | 201 | 0.070 |
Why?
| Surgical Procedures, Operative | 1 | 2010 | 243 | 0.070 |
Why?
| Social Justice | 1 | 2008 | 77 | 0.070 |
Why?
| Alcoholism | 1 | 2014 | 764 | 0.070 |
Why?
| Patient Education as Topic | 2 | 2012 | 733 | 0.070 |
Why?
| Gastroenterology | 1 | 2009 | 174 | 0.070 |
Why?
| Thromboembolism | 1 | 2007 | 101 | 0.070 |
Why?
| Liver Neoplasms | 1 | 2012 | 633 | 0.070 |
Why?
| Child | 3 | 2020 | 20636 | 0.070 |
Why?
| Diabetes Mellitus | 1 | 2015 | 994 | 0.070 |
Why?
| Linear Models | 3 | 2014 | 816 | 0.070 |
Why?
| Age Distribution | 1 | 2007 | 369 | 0.070 |
Why?
| Quality Improvement | 1 | 2014 | 1093 | 0.060 |
Why?
| Lung | 3 | 2023 | 3745 | 0.060 |
Why?
| Colonoscopy | 1 | 2008 | 234 | 0.060 |
Why?
| Biomedical Research | 1 | 2012 | 632 | 0.060 |
Why?
| Prazosin | 1 | 2005 | 23 | 0.060 |
Why?
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2005 | 37 | 0.060 |
Why?
| Longitudinal Studies | 2 | 2018 | 2706 | 0.060 |
Why?
| Azithromycin | 1 | 2005 | 91 | 0.060 |
Why?
| Administration, Cutaneous | 1 | 2004 | 121 | 0.060 |
Why?
| Myocardial Ischemia | 1 | 2006 | 247 | 0.060 |
Why?
| Arthritis, Rheumatoid | 1 | 2013 | 1088 | 0.060 |
Why?
| Proportional Hazards Models | 1 | 2007 | 1194 | 0.060 |
Why?
| Probability | 1 | 2004 | 304 | 0.050 |
Why?
| Cholesterol, LDL | 1 | 2006 | 357 | 0.050 |
Why?
| HIV Infections | 1 | 2018 | 2703 | 0.050 |
Why?
| Reference Values | 1 | 2004 | 776 | 0.050 |
Why?
| Immunologic Tests | 1 | 2022 | 16 | 0.050 |
Why?
| Double-Blind Method | 2 | 2004 | 1852 | 0.050 |
Why?
| Hospitals, Veterans | 2 | 2017 | 255 | 0.050 |
Why?
| Drug Administration Schedule | 1 | 2004 | 755 | 0.050 |
Why?
| Tobacco Products | 1 | 2023 | 110 | 0.050 |
Why?
| Muscles | 1 | 2023 | 322 | 0.050 |
Why?
| Immunoglobulins | 1 | 2022 | 157 | 0.050 |
Why?
| Fluoxetine | 1 | 2002 | 52 | 0.050 |
Why?
| Public Opinion | 1 | 2002 | 63 | 0.050 |
Why?
| Health Maintenance Organizations | 1 | 2002 | 97 | 0.050 |
Why?
| Dyspnea | 1 | 2023 | 238 | 0.050 |
Why?
| Risk Factors | 4 | 2021 | 9696 | 0.050 |
Why?
| Health Behavior | 1 | 2007 | 740 | 0.050 |
Why?
| Young Adult | 2 | 2015 | 12281 | 0.050 |
Why?
| Medicare | 2 | 2020 | 715 | 0.050 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2005 | 439 | 0.050 |
Why?
| Behavioral Risk Factor Surveillance System | 1 | 2021 | 49 | 0.040 |
Why?
| Accidental Falls | 1 | 2023 | 168 | 0.040 |
Why?
| Cardiovascular Diseases | 1 | 2013 | 1994 | 0.040 |
Why?
| Colorectal Neoplasms | 1 | 2008 | 746 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2022 | 331 | 0.040 |
Why?
| Pennsylvania | 1 | 2020 | 107 | 0.040 |
Why?
| Michigan | 1 | 2020 | 103 | 0.040 |
Why?
| Prospective Studies | 2 | 2018 | 7035 | 0.040 |
Why?
| Dose-Response Relationship, Drug | 1 | 2004 | 1943 | 0.040 |
Why?
| Data Collection | 2 | 2013 | 645 | 0.040 |
Why?
| Behavior Therapy | 1 | 2002 | 236 | 0.040 |
Why?
| Survivors | 1 | 2023 | 462 | 0.040 |
Why?
| Oral Health | 1 | 2021 | 129 | 0.040 |
Why?
| Continuity of Patient Care | 2 | 2014 | 275 | 0.040 |
Why?
| Length of Stay | 2 | 2015 | 1114 | 0.040 |
Why?
| Blood Pressure | 1 | 2006 | 1711 | 0.040 |
Why?
| Walking | 1 | 2023 | 494 | 0.040 |
Why?
| Attitude to Health | 1 | 2002 | 431 | 0.040 |
Why?
| Electronic Health Records | 2 | 2017 | 973 | 0.040 |
Why?
| Guideline Adherence | 1 | 2002 | 523 | 0.040 |
Why?
| Analysis of Variance | 2 | 2010 | 1266 | 0.040 |
Why?
| Pregnancy Complications | 1 | 2002 | 487 | 0.030 |
Why?
| Community Health Services | 1 | 2018 | 226 | 0.030 |
Why?
| Formative Feedback | 1 | 2016 | 26 | 0.030 |
Why?
| Prevalence | 1 | 2023 | 2541 | 0.030 |
Why?
| Self Report | 1 | 2021 | 796 | 0.030 |
Why?
| Behavior | 1 | 2016 | 91 | 0.030 |
Why?
| Health Status | 1 | 2021 | 747 | 0.030 |
Why?
| Vulnerable Populations | 1 | 2016 | 157 | 0.030 |
Why?
| Alcohol Withdrawal Delirium | 1 | 2014 | 7 | 0.030 |
Why?
| Mental Health | 1 | 2021 | 683 | 0.030 |
Why?
| Patient Acceptance of Health Care | 1 | 2020 | 756 | 0.030 |
Why?
| Alaska | 1 | 2014 | 81 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2016 | 478 | 0.030 |
Why?
| Factor Analysis, Statistical | 1 | 2014 | 283 | 0.030 |
Why?
| Physician-Nurse Relations | 1 | 2013 | 15 | 0.030 |
Why?
| Residence Characteristics | 1 | 2016 | 324 | 0.030 |
Why?
| Hospitals, Teaching | 1 | 2013 | 112 | 0.030 |
Why?
| Models, Psychological | 1 | 2014 | 306 | 0.020 |
Why?
| Health Services Research | 1 | 2015 | 389 | 0.020 |
Why?
| Patient Rights | 1 | 2012 | 11 | 0.020 |
Why?
| Focus Groups | 1 | 2014 | 452 | 0.020 |
Why?
| Decision Trees | 1 | 2012 | 90 | 0.020 |
Why?
| Models, Economic | 1 | 2012 | 53 | 0.020 |
Why?
| Body Weight | 1 | 2016 | 930 | 0.020 |
Why?
| Personal Autonomy | 1 | 2012 | 48 | 0.020 |
Why?
| Cost Savings | 1 | 2012 | 78 | 0.020 |
Why?
| Monte Carlo Method | 1 | 2012 | 140 | 0.020 |
Why?
| Program Evaluation | 1 | 2016 | 872 | 0.020 |
Why?
| Computer-Assisted Instruction | 1 | 2012 | 59 | 0.020 |
Why?
| Patient-Centered Care | 1 | 2016 | 493 | 0.020 |
Why?
| Patient Care Planning | 1 | 2012 | 148 | 0.020 |
Why?
| Radiotherapy | 1 | 2012 | 185 | 0.020 |
Why?
| Seizures | 1 | 2014 | 400 | 0.020 |
Why?
| Motivation | 1 | 2015 | 544 | 0.020 |
Why?
| Documentation | 1 | 2012 | 181 | 0.020 |
Why?
| Physician's Role | 1 | 2012 | 203 | 0.020 |
Why?
| Endarterectomy, Carotid | 1 | 2010 | 47 | 0.020 |
Why?
| Pregnancy | 2 | 2018 | 6355 | 0.020 |
Why?
| Cholecystectomy, Laparoscopic | 1 | 2010 | 51 | 0.020 |
Why?
| Prostatectomy | 1 | 2010 | 106 | 0.020 |
Why?
| Quality Assurance, Health Care | 1 | 2012 | 315 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2010 | 511 | 0.020 |
Why?
| Sex Factors | 1 | 2015 | 1942 | 0.020 |
Why?
| Cost-Benefit Analysis | 1 | 2012 | 567 | 0.020 |
Why?
| Health Personnel | 1 | 2014 | 645 | 0.020 |
Why?
| Observation | 1 | 2008 | 51 | 0.020 |
Why?
| Patient Participation | 1 | 2012 | 409 | 0.020 |
Why?
| Arthroplasty, Replacement, Hip | 1 | 2010 | 135 | 0.020 |
Why?
| Postoperative Care | 1 | 2009 | 235 | 0.020 |
Why?
| Genotype | 1 | 2013 | 1828 | 0.020 |
Why?
| Decision Support Techniques | 1 | 2012 | 396 | 0.020 |
Why?
| Educational Status | 1 | 2010 | 470 | 0.020 |
Why?
| Medicine | 1 | 2009 | 117 | 0.020 |
Why?
| Computer Simulation | 1 | 2012 | 936 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2013 | 2059 | 0.020 |
Why?
| Emotions | 1 | 2010 | 535 | 0.020 |
Why?
| Registries | 1 | 2013 | 1873 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2013 | 2703 | 0.010 |
Why?
| Predictive Value of Tests | 1 | 2010 | 1934 | 0.010 |
Why?
| Multivariate Analysis | 1 | 2006 | 1492 | 0.010 |
Why?
| Liver Transplantation | 1 | 2009 | 799 | 0.010 |
Why?
| Telephone | 1 | 2002 | 165 | 0.010 |
Why?
| Anxiety | 1 | 2008 | 951 | 0.010 |
Why?
| Reimbursement Mechanisms | 1 | 2002 | 84 | 0.010 |
Why?
| Medical Records | 1 | 2002 | 170 | 0.010 |
Why?
| Mass Screening | 1 | 2008 | 1145 | 0.010 |
Why?
| Obstetrics | 1 | 2002 | 161 | 0.010 |
Why?
| Regression Analysis | 1 | 2002 | 978 | 0.010 |
Why?
| Combined Modality Therapy | 1 | 2002 | 1199 | 0.010 |
Why?
| Health Promotion | 1 | 2002 | 716 | 0.010 |
Why?
|
|
Prochazka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|